Drugs / GRAdHIVNE1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06617091 | Jul 2025 → Mar 2027 expected | HIV infectious disease | International AIDS Vaccine Initiative | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRAdHIVNE1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06617091 ↗ |
| Modality | Vaccine | “Gorilla Adenovirus Vectored Networked Epitopes Vaccine” NCT06617091 ↗ |